Lung cancer Cancer
Conditions
Interventions
This is a multi-centre feasibility study taking place in two NHS Trusts across Yorkshire. It aims to deliver a tailored cancer rehabilitation service embedded within existing NHS cancer services. The
Sponsors
University of Hull
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Adults aged 18 years or older 2. Lung cancer, any stage, any type 3. Receiving any combination of chemotherapy, radiotherapy, and targeted therapy alongside surgery (if applicable) 4.Patients being treated curatively, palliatively, or with best supportive care
Exclusion criteria
Exclusion criteria: Any condition or circumstance which, in the opinion of the clinician, would make referral to the service inappropriate. This includes: 1. An unstable or acute medical condition (for example severe uncontrolled symptoms, unresolved pulmonary embolism, or decompensated heart failure), as determined by the participating clinical team 2. An underlying severe chronic condition or disease where systemic anti-cancer treatment is not considered appropriate by the treating oncologist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Referral uptake: Proportion of eligible patients referred to and accepting referral to the cancer rehabilitation service, measured using service referral and attendance records during the 12-month study period. 2. Programme engagement: Engagement with the rehabilitation programme, measured using Rehab Guru log-ins, exercise completion records and appointment attendance over 6 months. 3. Acceptability and feasibility: Acceptability, safety and feasibility of the rehabilitation service, measured using qualitative interviews, service user feedback surveys, clinical records and implementation data throughout the study period. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cancer treatment outcomes: treatment completion and delivery measured from medical records from baseline to 12 months. 2. Physical function measured using handgrip strength, standing balance, timed up and go (TUG), 30-second sit-to-stand (SPPB), bioelectrical impedance analysis (BIA) and the Australian Karnofsky Performance Scale (AKPS) at baseline, 3 months and 6 months. 3. Quality of life and nutritional status measured using EQ-5D-5L, EQ-VAS and Patient-Generated Subjective Global Assessment (PG-SGA) at baseline, 3 months and 6 months 4. Physical activity measured using the Short Questionnaire to Assess Health Enhancing Physical Activity (SQUASH), measured at baseline, 3 months and 6 months 5. Capability, opportunity and motivation for physical activity, measured using three COM-B/TDF-informed items at baseline, 3 months and 6 months 6. Sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI) at baseline, 3 months and 6 months 7. Healthcare utilisation measured using healthcare contacts recorded in medical records from baseline to 12 months 8. Survival measured using date and cause of death recorded in clinical records from baseline to 12 months | — |
Countries
England, United Kingdom
Contacts
Public ContactBuse Apel
Outcome results
None listed